Reproductive cancer screening endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells

Organisms1

Diseases55

Genital Neoplasms, Female Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Ovarian Neoplasms Neoplasms Pancreatic Neoplasms Breast Neoplasms Neoplasm Invasiveness Lung Neoplasms Prostatic Neoplasms Endometrial Hyperplasia Colonic Neoplasms Stomach Neoplasms Uterine Neoplasms Neoplasm Metastasis Carcinoma Genetic Predisposition to Disease Adenocarcinoma Uterine Cervical Neoplasms Cystadenocarcinoma, Serous Neoplasms, Multiple Primary Neoplasm Recurrence, Local Neoplasms, Second Primary Colorectal Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms Disease Progression Skin Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Liver Neoplasms Cell Transformation, Neoplastic Carcinoma, Non-Small-Cell Lung Cystadenocarcinoma, Papillary Neoplasms, Hormone-Dependent Thyroid Neoplasms Rectal Neoplasms Kidney Neoplasms Adenocarcinoma, Mucinous Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Radiation-Induced Neoplasms, Glandular and Epithelial Precancerous Conditions Gastrointestinal Neoplasms Bone Neoplasms Mouth Neoplasms Esophageal Neoplasms Adenocarcinoma, Papillary Head and Neck Neoplasms Carcinoma, Papillary Neoplasms, Experimental Carcinoma, Pancreatic Ductal Microsatellite Instability Neovascularization, Pathologic

Chemicals and Drugs34

Simazine Neoplasm Proteins Tumor Markers, Biological Tamoxifen DNA, Neoplasm Receptors, Estrogen Estrogens Receptors, Progesterone Antineoplastic Agents Cancer Vaccines Antineoplastic Agents, Hormonal RNA, Messenger Antigens, Neoplasm Progestins Receptor, erbB-2 RNA, Small Interfering Tumor Suppressor Protein p53 Estrogen Antagonists PTEN Phosphohydrolase Estrogen Receptor alpha Tumor Suppressor Proteins Paclitaxel Prostate-Specific Antigen Cisplatin Contraceptives, Oral Anticarcinogenic Agents Nuclear Proteins Antineoplastic Agents, Phytogenic RNA, Neoplasm DNA-Binding Proteins MicroRNAs Estrogen Receptor Modulators Fluorouracil Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Early Detection of Cancer Neoplasm Staging Prognosis Risk Risk Factors Hysterectomy Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Odds Ratio Reverse Transcriptase Polymerase Chain Reaction Registries Immunohistochemistry Risk Assessment Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Gene Expression Profiling Disease-Free Survival Xenograft Model Antitumor Assays Neoplasm Grading Incidence Neoplasm Transplantation Blotting, Western Estrogen Replacement Therapy Sensitivity and Specificity Chemotherapy, Adjuvant SEER Program Kaplan-Meier Estimate Combined Modality Therapy Logistic Models Multivariate Analysis Oligonucleotide Array Sequence Analysis Polymerase Chain Reaction Cohort Studies Questionnaires Salpingectomy Transplantation, Heterologous Lymph Node Excision Immunoenzyme Techniques Molecular Targeted Therapy Confidence Intervals Drug Screening Assays, Antitumor Tissue Array Analysis Treatment Outcome Body Mass Index Tumor Burden Predictive Value of Tests Neoplasms, Experimental Clinical Trials as Topic Radiotherapy, Adjuvant Radiotherapy

Psychiatry and Psychology1

Phenomena and Processes29

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Odds Ratio Postmenopause Mutation Drug Resistance, Neoplasm DNA Methylation Genotype Sensitivity and Specificity Cell Proliferation Germ-Line Mutation Polymorphism, Genetic Apoptosis Cell Growth Processes Cell Survival Gene Silencing Down-Regulation Cell Division Menopause Cell Cycle Cell Movement Genes, Tumor Suppressor Promoter Regions, Genetic Dose-Response Relationship, Drug Microsatellite Repeats Body Mass Index Premenopause Microsatellite Instability

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Survival Rate Registries Incidence SEER Program Questionnaires

Named Groups1

Health Care27

Risk Risk Factors Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Odds Ratio Registries Risk Assessment Case-Control Studies Age Factors Disease-Free Survival Incidence Sensitivity and Specificity National Cancer Institute (U.S.)SEER Program Kaplan-Meier Estimate Logistic Models Multivariate Analysis Cohort Studies Questionnaires Confidence Intervals Treatment Outcome Body Mass Index Predictive Value of Tests Clinical Trials as Topic

Geographicals3

United States China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Simazine Genital Neoplasms, Female Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Early Detection of Cancer Ovarian Neoplasms Neoplasms Pancreatic Neoplasms Breast Neoplasms Neoplasm Invasiveness Lung Neoplasms Neoplasm Staging Prostatic Neoplasms Gene Expression Regulation, Neoplastic Endometrial Hyperplasia Colonic Neoplasms Stomach Neoplasms Uterine Neoplasms Prognosis Neoplasm Metastasis Neoplasm Proteins Tumor Markers, Biological Carcinoma Risk Risk Factors Cell Line, Tumor Genetic Predisposition to Disease Adenocarcinoma Mice, Nude Hysterectomy Tamoxifen Survival Rate Survival Analysis Endometrium Retrospective Studies DNA, Neoplasm Uterine Cervical Neoplasms Cystadenocarcinoma, Serous Neoplasms, Multiple Primary Neoplasm Recurrence, Local Neoplasms, Second Primary Colorectal Neoplasms Receptors, Estrogen Follow-Up Studies Prospective Studies Odds Ratio Estrogens Postmenopause Reverse Transcriptase Polymerase Chain Reaction Receptors, Progesterone Antineoplastic Agents Cancer Vaccines Registries Immunohistochemistry Antineoplastic Agents, Hormonal Mutation Risk Assessment Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms Disease Progression Skin Neoplasms United States RNA, Messenger Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Carcinoma, Squamous Cell Case-Control Studies Gene Expression Profiling DNA Methylation Age Factors Disease-Free Survival Adenocarcinoma, Clear Cell Xenograft Model Antitumor Assays Neoplasm Grading Genotype Incidence Neoplasm Transplantation Blotting, Western Antigens, Neoplasm Liver Neoplasms Cell Transformation, Neoplastic Estrogen Replacement Therapy Carcinoma, Non-Small-Cell Lung Cystadenocarcinoma, Papillary Progestins Sensitivity and Specificity Cell Proliferation Neoplasms, Hormone-Dependent Survivors National Cancer Institute (U.S.)Thyroid Neoplasms Receptor, erbB-2 Germ-Line Mutation Rectal Neoplasms Kidney Neoplasms RNA, Small Interfering Adenocarcinoma, Mucinous Chemotherapy, Adjuvant SEER Program

No FAQ available that match "reproductive cancer screening endometrial cancer vulvar neoplasms"